Cargando…

Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis

BACKGROUND: The clinical significance of stem cell therapy in the treatment of dilated cardiomyopathy remains unclear. This systemic appraisal and meta-analysis aimed to assess the efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy. After searching the PubMed, Embase, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rong, Shu-Ling, Wang, Ze-Kun, Zhou, Xue-Dong, Wang, Xiao-Lin, Yang, Zhi-Ming, Li, Bao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624954/ https://www.ncbi.nlm.nih.gov/pubmed/31296244 http://dx.doi.org/10.1186/s12967-019-1966-4

Ejemplares similares

Effects of stem cell therapy on dilated cardiomyopathy
por: Jiao, Rong, et al.
Publicado: (2014)

Efficacy and safety of supramaximal titrated inhibition of renin‐angiotensin‐aldosterone system in idiopathic dilated cardiomyopathy
por: He, Zheng, et al.
Publicado: (2015)

Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis
por: Tong, Xinyu, et al.
Publicado: (2023)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials
por: Wei, Jingjing, et al.
Publicado: (2022)

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy
por: Tompkins, Bryon A., et al.
Publicado: (2018)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

The role of Asprosin in patients with dilated cardiomyopathy
por: Wen, Ming-Shien, et al.
Publicado: (2020)

Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials
por: Weng, Yayun, et al.
Publicado: (2021)

Efficacy and Safety of ARRY-371797 in LMNA-Related Dilated Cardiomyopathy: A Phase 2 Study
por: MacRae, Calum A., et al.
Publicado: (2022)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Association between late gadolinium enhancement and outcome in dilated cardiomyopathy: A meta-analysis
por: Feng, Xin-Yi, et al.
Publicado: (2023)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

Clinical efficacy of carvedilol treatment for dilated cardiomyopathy: A meta-analysis of randomized controlled trials
por: Li, Tao, et al.
Publicado: (2019)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Risk factors and a Bayesian network model to predict ischemic stroke in patients with dilated cardiomyopathy
por: Fan, Ze-Xin, et al.
Publicado: (2022)

Trophoblast Stem-Cell-Derived Exosomes Improve Doxorubicin-Induced Dilated Cardiomyopathy by Modulating the let-7i/YAP Pathway
por: Ni, Jie, et al.
Publicado: (2020)

Circular RNA Expression for Dilated Cardiomyopathy in Hearts and Pluripotent Stem Cell–Derived Cardiomyocytes
por: Zhang, Yiyu, et al.
Publicado: (2021)

Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review
por: Hoeeg, Cecilie, et al.
Publicado: (2020)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Whole exome sequencing identifies a KCNJ12 mutation as a cause of familial dilated cardiomyopathy
por: Yuan, Hai-Xin, et al.
Publicado: (2017)

Hypoparathyroidism and reversible dilated cardiomyopathy
por: Babu, M. Suresh, et al.
Publicado: (2011)

The Mutations Associated with Dilated Cardiomyopathy
por: Parvari, Ruti, et al.
Publicado: (2012)

Calreticulin Induces Dilated Cardiomyopathy
por: Lee, Dukgyu, et al.
Publicado: (2013)

Infants with dilated cardiomyopathy and hypocalcemia
por: Sanyal, Debmalya, et al.
Publicado: (2013)

LMNA-related dilated cardiomyopathy
por: Vaikhanskaya, Tatiyana, et al.
Publicado: (2014)

Rhinovirus-associated dilated cardiomyopathy
por: Chow, Jeffrey, et al.
Publicado: (2020)

Myocarditis and idiopathic dilated cardiomyopathy
por: Brown, Charles A., et al.
Publicado: (1995)

Echocardiographic Advances in Dilated Cardiomyopathy
por: Faggiano, Andrea, et al.
Publicado: (2021)

Transcriptomics and Beyond in Dilated Cardiomyopathy
por: Cowan, Jason R., et al.
Publicado: (2023)

The Genetic Evaluation of Dilated Cardiomyopathy
por: Bui, Quan M., et al.
Publicado: (2023)

Systematic review and meta-analysis appraising efficacy and safety of adrenaline for adult cardiopulmonary resuscitation
por: Ludwin, Kobi, et al.
Publicado: (2021)

Cushing Syndrome in the Setting of Chronic Dilated Cardiomyopathy: Can Treatment Improve Chronic Dilated Cardiomyopathy?
por: Pathak, Leilani, et al.
Publicado: (2021)

Efficacy and safety of pneumatic dilation in achalasia: A systematic review and meta‐analysis
por: van Hoeij, Froukje B., et al.
Publicado: (2019)

Oral Chinese Herbal Medicine for Treatment of Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis
por: Zhu, Yu-Shuo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_83o5fri8d0nh9o670bvvedi0uj